CareFusion is a subsidiary of Becton Dickinson specializing in two areas: reducing medication errors and prevention of health care-associated infections.
CareFusion was spun-off from Cardinal Health on August 31, 2009. Businesses that were part of the Clinical and Medical Products segment of Cardinal Health were spun off to create CareFusion. CareFusion began publicly trading on the New York Stock Exchange on September 1, 2009, with former CEO David Schlotterbeck.
On May 17, 2010, CareFusion acquired Medegen, Inc. for US$ 225 million in cash. On February 1, 2011, Kieran T. Gallahue was named CareFusion's chairman and CEO. In April 2012, CareFusion sold the Nicolet operating unit to Natus Medical Incorporated for $58 million. On July 7, 2012, CareFusion acquired U.K. Medical Limited, a distributor of medical products to the National Health Service and private health care sector in the United Kingdom. In November 2012, CareFusion acquired Intermed Equipamento Medico Hospitalar Ltda, a privately held respiratory technologies company based in Cotia, Brazil. Intermed designs, manufactures and markets ventilators and respiratory care devices for infant, pediatric and adult patients that are used in hospitals in Brazil, Latin America and Europe.
On November 18, 2013, CareFusion acquired Vital Signs Inc., a medical device manufacturing business, with the exception of European operations from GE Healthcare. In 2013, CareFusion bought 40% of the Israeli company Caesarea Medical Electronics.
In January 2014, the United States Department of Justice reached a USD $40.1 million settlement with CareFusion. The Department of Justice alleged that CareFusion violated the False Claims Act by promoting the sale of its drug ChloraPrep for uses that were not approved by the FDA. ChloraPrep is the commercial name under which CareFusion produced the drug chlorhexidine, used to clean the skin before surgery. In 2017, this case was called into question and came under review by the DOJ because the lead attorney for the DOJ serving as Assistant Attorney General in the case, Jeffery Wertkin was arrested by the FBI on January 31, 2017 for allegedly attempting to sell a copy of a complaint in a secret whistleblower suit that was under seal.
On October 5, 2014, BD announced its acquisition of CareFusion for $58 USD per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions. The acquisition was completed on March 17, 2015.
Video CareFusion
References
Maps CareFusion
External links
- CareFusion Official Web Site
Source of the article : Wikipedia
0 Comments